PAVmed (PAVM) Competitors $0.52 +0.03 (+6.16%) Closing price 04:00 PM EasternExtended Trading$0.51 -0.01 (-1.73%) As of 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock PAVM vs. COCH, VVOS, RVP, FEMY, PETV, ICU, DRIO, NXGL, IRIX, and ALURShould you be buying PAVmed stock or one of its competitors? The main competitors of PAVmed include Envoy Medical (COCH), Vivos Therapeutics (VVOS), Retractable Technologies (RVP), Femasys (FEMY), PetVivo (PETV), SeaStar Medical (ICU), DarioHealth (DRIO), NexGel (NXGL), IRIDEX (IRIX), and Allurion Technologies (ALUR). These companies are all part of the "medical equipment" industry. PAVmed vs. Its Competitors Envoy Medical Vivos Therapeutics Retractable Technologies Femasys PetVivo SeaStar Medical DarioHealth NexGel IRIDEX Allurion Technologies Envoy Medical (NASDAQ:COCH) and PAVmed (NASDAQ:PAVM) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, dividends, risk, media sentiment, profitability, analyst recommendations and institutional ownership. Does the media favor COCH or PAVM? In the previous week, Envoy Medical had 2 more articles in the media than PAVmed. MarketBeat recorded 4 mentions for Envoy Medical and 2 mentions for PAVmed. PAVmed's average media sentiment score of 0.00 beat Envoy Medical's score of -0.36 indicating that PAVmed is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Envoy Medical 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral PAVmed 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has stronger earnings and valuation, COCH or PAVM? PAVmed has higher revenue and earnings than Envoy Medical. Envoy Medical is trading at a lower price-to-earnings ratio than PAVmed, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEnvoy Medical$220K114.45-$20.80M-$1.43-0.82PAVmed$2.99M3.81$39.79M$1.160.45 Do analysts recommend COCH or PAVM? Envoy Medical presently has a consensus price target of $9.25, suggesting a potential upside of 690.60%. PAVmed has a consensus price target of $19.00, suggesting a potential upside of 3,560.89%. Given PAVmed's higher probable upside, analysts plainly believe PAVmed is more favorable than Envoy Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Envoy Medical 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00PAVmed 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do institutionals & insiders hold more shares of COCH or PAVM? 8.6% of Envoy Medical shares are owned by institutional investors. Comparatively, 19.9% of PAVmed shares are owned by institutional investors. 58.9% of Envoy Medical shares are owned by insiders. Comparatively, 7.3% of PAVmed shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Which has more volatility and risk, COCH or PAVM? Envoy Medical has a beta of 2.21, suggesting that its stock price is 121% more volatile than the S&P 500. Comparatively, PAVmed has a beta of 1.08, suggesting that its stock price is 8% more volatile than the S&P 500. Is COCH or PAVM more profitable? PAVmed has a net margin of 7,144.80% compared to Envoy Medical's net margin of -10,961.26%. Company Net Margins Return on Equity Return on Assets Envoy Medical-10,961.26% N/A -236.14% PAVmed 7,144.80%N/A -20.96% SummaryPAVmed beats Envoy Medical on 9 of the 14 factors compared between the two stocks. Get PAVmed News Delivered to You Automatically Sign up to receive the latest news and ratings for PAVM and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PAVM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PAVM vs. The Competition Export to ExcelMetricPAVmedMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$11.38M$6.87B$5.73B$9.76BDividend YieldN/A1.28%4.40%4.08%P/E Ratio0.4527.0230.3826.03Price / Sales3.8176.28428.56103.94Price / CashN/A22.3525.7828.79Price / Book-0.564.889.706.08Net Income$39.79M$176.42M$3.27B$265.64M7 Day Performance20.98%2.45%3.95%3.11%1 Month Performance-10.79%-2.06%3.81%0.39%1 Year Performance-35.93%7.71%31.26%18.52% PAVmed Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PAVMPAVmed4.4315 of 5 stars$0.52+6.2%$19.00+3,560.9%-33.5%$11.38M$2.99M0.4590Gap UpHigh Trading VolumeCOCHEnvoy Medical2.9871 of 5 stars$1.35-4.9%$9.25+585.2%-59.7%$30.56M$220K-0.9434News CoverageHigh Trading VolumeVVOSVivos Therapeutics0.7106 of 5 stars$4.45+8.3%$4.82+8.2%+71.2%$24.21M$15.03M-2.57160Earnings ReportRVPRetractable Technologies2.0445 of 5 stars$0.80+0.7%N/A-11.8%$23.96M$33.75M-1.48240Positive NewsFEMYFemasys3.3501 of 5 stars$0.70-1.4%$7.33+947.5%-51.9%$23.13M$1.63M-0.8130News CoveragePositive NewsGap DownPETVPetVivoN/A$0.82+1.7%N/A+43.6%$23.01M$1.05M-1.8320ICUSeaStar Medical0.4094 of 5 stars$0.83+3.2%N/A-86.1%$22.44M$140K-0.322DRIODarioHealth1.3459 of 5 stars$0.45+0.4%$2.00+344.6%-40.8%$20.38M$27.04M-0.68200Negative NewsStock SplitNXGLNexGel0.8812 of 5 stars$2.31-4.9%N/A-9.2%$19.60M$8.69M-5.7710Gap UpIRIXIRIDEX1.532 of 5 stars$1.17+3.5%N/A-33.9%$19.20M$48.67M-3.55120ALURAllurion Technologies2.9511 of 5 stars$2.38-1.0%$22.83+861.4%-87.0%$17.90M$32.11M-0.19501Earnings ReportGap Down Related Companies and Tools Related Companies Envoy Medical Competitors Vivos Therapeutics Competitors Retractable Technologies Competitors Femasys Competitors PetVivo Competitors SeaStar Medical Competitors DarioHealth Competitors NexGel Competitors IRIDEX Competitors Allurion Technologies Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PAVM) was last updated on 8/26/2025 by MarketBeat.com Staff From Our Partners“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredCover all your expenses with just $118,000 invested?Generate up to $5,000/month with 10X less money? That's what every financial advisor tells you. But I just ...Investors Alley | SponsoredFed Decision Warning: How to Protect Your Wealth Before September 30th On September 17th, the Fed faces an impossible choice—and Wall Street insiders are already preparing for the...American Alternative | SponsoredElon Musk’s New TechnologyElon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a n...Paradigm Press | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump’s national nightmare is hereWhile the headlines focus on global conflicts, there’s a very different crisis brewing at home. Washington has...Porter & Company | SponsoredIt’s game over for Central BanksCentral banks are losing control. Inflation isn’t fixed, debt is exploding, and stocks have never looked more ...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PAVmed Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PAVmed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access